Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vedat Hamuryudan

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Rheumatology International|July 2, 2022
Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet's syndromeAyse Ozdede, Okan Kadir Nohut, Zeynep Atli, et al.
Seminars in Arthritis and Rheumatism|January 29, 2008
Atherosclerosis in Behçet's SyndromeEmire Seyahi, Serdal Ugurlu, Rana Cumali, et al.
Rheumatology International|August 17, 2023
Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysisDidar Ucar, Sinem Nihal Esatoglu, Emir Cerme, et al.
Rheumatology (Oxford, England)|December 17, 2019
Long term follow-up of Behçet's syndrome patients treated with cyclophosphamideMert Gurcan, Sinem Nihal Esatoglu, Vedat Hamuryudan, et al.
Clinical and Experimental Rheumatology|October 30, 2016
Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet's syndrome patients with pulmonary artery involvement during follow-upSinem Nihal Esatoglu, Emire Seyahi, Serdal Ugurlu, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Direct and indirect healthcare costs of rheumatoid arthritis patients in TurkeyVedat Hamuryudan, Haner Direskeneli, Ihsan Ertenli, et al.
Rheumatology International|June 10, 2021
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderlyEmire Seyahi, Guldaran Bakhdiyarli, Mert Oztas, et al.
Journal of Neurology|July 8, 2025
Central nervous system involvement and mimickers in ANCA associated vasculitisYeliz Yagiz Ozogul, Sinem Nihal Esatoglu, Murat Ozogul, et al.
Rheumatology International|November 26, 2021
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndromeGuzin Ozcifci, Tahacan Aydin, Zeynep Atli, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Rheumatology International|July 2, 2022
Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet's syndromeAyse Ozdede, Okan Kadir Nohut, Zeynep Atli, et al.
Seminars in Arthritis and Rheumatism|January 29, 2008
Atherosclerosis in Behçet's SyndromeEmire Seyahi, Serdal Ugurlu, Rana Cumali, et al.
Rheumatology International|August 17, 2023
Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysisDidar Ucar, Sinem Nihal Esatoglu, Emir Cerme, et al.
Rheumatology (Oxford, England)|December 17, 2019
Long term follow-up of Behçet's syndrome patients treated with cyclophosphamideMert Gurcan, Sinem Nihal Esatoglu, Vedat Hamuryudan, et al.
Clinical and Experimental Rheumatology|October 30, 2016
Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet's syndrome patients with pulmonary artery involvement during follow-upSinem Nihal Esatoglu, Emire Seyahi, Serdal Ugurlu, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Direct and indirect healthcare costs of rheumatoid arthritis patients in TurkeyVedat Hamuryudan, Haner Direskeneli, Ihsan Ertenli, et al.
Rheumatology International|June 10, 2021
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderlyEmire Seyahi, Guldaran Bakhdiyarli, Mert Oztas, et al.
Journal of Neurology|July 8, 2025
Central nervous system involvement and mimickers in ANCA associated vasculitisYeliz Yagiz Ozogul, Sinem Nihal Esatoglu, Murat Ozogul, et al.
Rheumatology International|November 26, 2021
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndromeGuzin Ozcifci, Tahacan Aydin, Zeynep Atli, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Pageof 9